Can LDL-cholesterol targets be achieved in a population at high risk? Results of the non-interventional study ACT II.

Bernd Eber; Dominik Lautsch; Christiane Fauer; Heinz Drexel; Karl Peter Pfeiffer; Otto Traindl; Max Pichler

doi:10.1185/03007995.2012.717919

Can LDL-cholesterol targets be achieved in a population at high risk? Results of the non-interventional study ACT II.

Bernd Eber, Dominik Lautsch, Christiane Fauer, Heinz Drexel, Karl Peter Pfeiffer, Otto Traindl, Max Pichler

Research output: Contribution to journal › Original Article › peer-review

8 Citations (Web of Science)

Original language	English
Pages (from-to)	1447-1454
Journal	CURRENT MEDICAL RESEARCH AND OPINION
Volume	28
Issue number	9
DOIs	https://doi.org/10.1185/03007995.2012.717919
Publication status	Published - 2012

Keywords

SECONDARY PREVENTION
CONTROLLED-TRIAL
CLINICAL-TRIALS
40 MG
DISEASE
EZETIMIBE
EFFICACY
DYSLIPIDEMIA
ATORVASTATIN
UPTITRATION

Access to Document

10.1185/03007995.2012.717919

Cite this

@article{e1f96d3cc79f4a47adf395b05daf567b,

title = "Can LDL-cholesterol targets be achieved in a population at high risk? Results of the non-interventional study ACT II.",

keywords = "SECONDARY PREVENTION, CONTROLLED-TRIAL, CLINICAL-TRIALS, 40 MG, DISEASE, EZETIMIBE, EFFICACY, DYSLIPIDEMIA, ATORVASTATIN, UPTITRATION",

author = "Bernd Eber and Dominik Lautsch and Christiane Fauer and Heinz Drexel and Pfeiffer, {Karl Peter} and Otto Traindl and Max Pichler",

year = "2012",

doi = "10.1185/03007995.2012.717919",

language = "English",

volume = "28",

pages = "1447--1454",

journal = "CURRENT MEDICAL RESEARCH AND OPINION",

issn = "0300-7995",

publisher = "LibraPharm, Ltd. ",

number = "9",

}

TY - JOUR

T1 - Can LDL-cholesterol targets be achieved in a population at high risk? Results of the non-interventional study ACT II.

AU - Eber, Bernd

AU - Lautsch, Dominik

AU - Fauer, Christiane

AU - Drexel, Heinz

AU - Pfeiffer, Karl Peter

AU - Traindl, Otto

AU - Pichler, Max

PY - 2012

Y1 - 2012

KW - SECONDARY PREVENTION

KW - CONTROLLED-TRIAL

KW - CLINICAL-TRIALS

KW - 40 MG

KW - DISEASE

KW - EZETIMIBE

KW - EFFICACY

KW - DYSLIPIDEMIA

KW - ATORVASTATIN

KW - UPTITRATION

U2 - 10.1185/03007995.2012.717919

DO - 10.1185/03007995.2012.717919

M3 - Original Article

C2 - 22856551

SN - 0300-7995

VL - 28

SP - 1447

EP - 1454

JO - CURRENT MEDICAL RESEARCH AND OPINION

JF - CURRENT MEDICAL RESEARCH AND OPINION

IS - 9

ER -